Americas (WHO region) vs Kazakhstan: Estimated antiretroviral therapy coverage among children
Americas (WHO region)
48
in 2025
Kazakhstan
76
in 2025
Americas (WHO region) rank
6th
Kazakhstan rank
8th
Estimated antiretroviral therapy coverage among children over time
- Americas (WHO region)
- Kazakhstan
How they compare
Kazakhstan currently reports 76 against 48 in Americas (WHO region), a difference of 28.
That makes Kazakhstan's figure about 1.6 times Americas (WHO region)'s.
The two have swapped places 1 time across 26 shared years of data; in 2000 it was Americas (WHO region) ahead.
Americas (WHO region) ranks 6th and Kazakhstan ranks 8th of 13 groups.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Americas (WHO region) | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.5 | 15.7 | 4.2 | Kazakhstan |
| 2010s | 38 | 77.5 | 39.5 | Kazakhstan |
| 2020s | 44.67 | 71.83 | 27.17 | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among children, Americas (WHO region) or Kazakhstan?
- Kazakhstan, at 76 against 48 in Americas (WHO region) as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among children between Americas (WHO region) and Kazakhstan?
- 28, with Kazakhstan ahead.
- How many years of comparable data are there for Americas (WHO region) and Kazakhstan?
- 26 years are reported by both, from 2000 to 2025.
- How do Americas (WHO region) and Kazakhstan rank globally for estimated antiretroviral therapy coverage among children?
- Americas (WHO region) ranks 6th and Kazakhstan ranks 8th of 13 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among children. Statizoid refreshes it automatically from the source and publishes the full history for both places.